Danbury Hospital is a 456-bed hospital in Danbury, Connecticut serving patients in Fairfield County, Connecticut, as well as Westchester County and Putnam County, New York. The hospital has 3,300 employees and is part of the Nuvance Health system.

There are 456 beds in Danbury Hospital.

During the past decade, Danbury Hospital conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 41 clinical trials were completed, i.e. on average, 65.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 27 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Danbury Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "Danbury Hospital" with 7 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored and "Alliance for Clinical Trials in Oncology" with 5 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Danbury Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Danbury Hospital" are "Heart Failure" (7 trials), "Ovarian Seromucinous Carcinoma" (6 trials), "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Danbury Hospital" in a lesser frequency.

Most popular intervention types in "Danbury Hospital" are "Drug" (62 trials), "Other" (50 trials), "Biological" (30 trials), "Procedure" (21 trials) and "Device" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (24 trials), "Quality-of-Life Assessment" (21 trials), "Paclitaxel" (14 trials), "Questionnaire Administration" (14 trials) and "Computed Tomography" (13 trials). Other intervention names were less common.

The vast majority of trials in "Danbury Hospital" are 77 trials for "All" genders and 22 trials for "Female" genders.

Currently, there are NaN active trials in "Danbury Hospital". undefined are not yet recruiting, 14 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Danbury Hospital, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Danbury Hospital, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 12 trials that are defined as “Not Applicable".